F2 Bioscience I 2017 Ltd

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Geneva, Switzerland
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Rachel Higham /s/ Ivan Bedford, for F2 Bioscience I 2017 Limited
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for F2 Bioscience I 2017 Ltd

Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
1,305,873
Estimated value
$16,271,178
Report date
21 Jun 2022
Price
$12.46
Ownership
F2 Vision SCS
Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
1,136,525
Estimated value
$14,161,102
Report date
21 Jun 2022
Price
$12.46
Ownership
By Globeways Holdings Ltd.
Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
622,175
Estimated value
$7,752,301
Report date
21 Jun 2022
Price
$12.46
Ownership
By F2-TPO Investments, LLC
Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
537,392
Estimated value
$6,695,904
Report date
23 Jun 2022
Price
$12.46
Ownership
Direct
Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
325,333
Estimated value
$4,053,649
Report date
21 Jun 2022
Price
$12.46
Ownership
By F2 MG Ltd.
Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
214,798
Estimated value
$2,676,383
Report date
21 Jun 2022
Price
$12.46
Ownership
By F2 MC, LLC
Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
112,507
Estimated value
$1,401,837
Report date
21 Jun 2022
Price
$12.46
Ownership
By Morana Jovan-Embiricos
Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
104,762
Estimated value
$1,305,335
Report date
21 Jun 2022
Price
$12.46
Ownership
By F2 GC, LLC
Form 4 holding 10%+ Owner

Cullinan Oncology, Inc.

Security class
Common Stock
Shares / value
71,599
Estimated value
$892,124
Report date
21 Jun 2022
Price
$12.46
Ownership
By F2 Bio TD, LLC

Insider Reports Filed by F2 Bioscience I 2017 Ltd

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .